欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号HU/H/0532/001
药品名称ZAFRILLA
活性成分
    • Dienogest 2.0 mg
剂型Tablet
上市许可持有人Gedeon Richter Plc. Gyömrői út 19-21. 1103 Budapest Hungary
参考成员国 - 产品名称Hungary (HU)
ZAFRILLA 2 mg tabletta
互认成员国 - 产品名称
    • Germany (DE)
      Zafrilla 2 mg Tabletten
    • Denmark (DK)
    • Belgium (BE)
      Zafrilla 2 mg comprimés
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Zafrilla
    • Lithuania (LT)
      Sawis 2 mg tabletės
    • Bulgaria (BG)
      ZAFRILLA
    • Czechia (CZ)
      Zafrilla 2 mg tablets
    • Romania (RO)
      Zafrilla 2 mg comprimate
    • Slovakia (SK)
      Zafrilla 2 mg tablety
    • Malta (MT)
    • Croatia (HR)
      Zafrilla 2 mg tablete
许可日期2018/12/13
最近更新日期2024/09/09
药物ATC编码
    • G03DB08 dienogest
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase